CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)

CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)

Cell-based therapy offers great promise for treating degenerative diseases. Although autologous cell-based therapy is ideal, it may be impractical due to the high manufacturing cost and long production time. Allogeneic cell-based therapy offers a more cost-effective alternative; however, the risk of...

書目詳細資料
Main Authors:	Nontaphat Thongsin, Siriwal Suwanpitak, Methichit Wattanapanitch
格式:	Article
語言:	English
出版:	Elsevier 2023-09-01
叢編:	Stem Cell Research
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S1873506123001241

相似書籍

Generation of a homozygous TIGIT gene knockout (TIGIT−/−) human iPSC line (MUSIi001-A-3) using CRISPR/Cas9 system
由: Jakkrapatra Srisantitham, et al.
出版: (2024-12-01)

Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers
由: Nontaphat Thongsin, et al.
出版: (2024-11-01)

A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors.
由: Koollawat Chupradit, et al.
出版: (2022-01-01)

Generation of an induced pluripotent stem cell line (MUSIi015-A) from a diabetic patient carrying mutations in ZYG11A (p.L475P) and GATA6 (p.E51K)
由: Siriwal Suwanpitak, et al.
出版: (2022-08-01)

A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity.
由: Nontaphat Thongsin, et al.
出版: (2022-01-01)

Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual
由: Ratchapong Netsrithong, et al.
出版: (2019-08-01)

Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system
由: Kongtana Trakarnsanga, et al.
出版: (2022-09-01)

Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar fibroblasts using Sendai viral vectors
由: Methichit Wattanapanitch, et al.
出版: (2018-03-01)

Establishment of an integration-free induced pluripotent stem cell line (MUSIi005-A) from exfoliated renal epithelial cells
由: Bootsakorn Boonkaew, et al.
出版: (2018-07-01)

Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells
由: Ratchapong Netsrithong, et al.
出版: (2020-11-01)

Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
由: Methichit Wattanapanitch
出版: (2019-01-01)

Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia
由: Nutnicha Tantarungsee, et al.
出版: (2019-07-01)

A live single-cell reporter system reveals drug-induced plasticity of a cancer stem cell-like population in cholangiocarcinoma
由: Krittiyabhorn Kongtanawanich, et al.
出版: (2024-09-01)

CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock
由: Jordi Miatello, et al.
出版: (2022-11-01)

Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing
由: Johanna Heider, et al.
出版: (2022-10-01)

One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
由: Methichit Wattanapanitch, et al.
出版: (2018-02-01)

Episomal vector-based generation of human induced pluripotent stem cell line MUSIi020-A from peripheral blood T-cells
由: Ponthip Pratumkaew, et al.
出版: (2022-10-01)

CRISPR/Cas9-mediated targeted chromosome elimination
由: Erwei Zuo, et al.
出版: (2017-11-01)

Generation of induced pluripotent stem cell lines carrying monoallelic (UCSFi001-A-60) or biallelic (UCSFi001-A-61; UCSFi001-A-62) frameshift variants in CACNA1A using CRISPR/Cas9
由: Marina P. Hommersom, et al.
出版: (2022-05-01)

CRISPR/Cas9-based GLA knockout to generate the female Fabry disease human induced pluripotent stem cell line MHHi001-A-15
由: Malte Juchem, et al.
出版: (2024-09-01)

Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9
由: Caterina Gargano, et al.
出版: (2023-12-01)

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
由: Chenhe Su, et al.
出版: (2021-08-01)

CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches
由: Elise Ramia, et al.
出版: (2019-03-01)

Generation of miR-15a/16-1 cluster-deficient human induced pluripotent stem cell line (DMBi001-A-2) using CRISPR/Cas9 gene editing
由: Jacek Stępniewski, et al.
出版: (2023-04-01)

Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9
由: Laure Chatrousse, et al.
出版: (2023-10-01)

Elimination of GGTA1, CMAH, β4GalNT2 and CIITA genes in pigs compromises human versus pig xenogeneic immune reactions
由: Jing Xu, et al.
出版: (2024-08-01)

Elimination of bla KPC−2-mediated carbapenem resistance in Escherichia coli by CRISPR-Cas9 system
由: Shuan Tao, et al.
出版: (2023-10-01)

CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
由: Hassen S Wollebo, et al.
出版: (2015-01-01)

CRISPR-Cas gene perturbation and editing in human induced pluripotent stem cells
由: van Essen, M, et al.
出版: (2021)

Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease
由: Seongyea Jo, et al.
出版: (2023-06-01)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
由: Huan Liu, et al.
出版: (2022-06-01)

CIITA and its dual roles in MHC gene transcription
由: Dinah S. Singer, et al.
出版: (2013-12-01)

MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer.
由: Lydie M O Barbeau, et al.
出版: (2025-01-01)

Generation of induced pluripotent stem cell line (UCSFi001-A-77) carrying a biallelic frameshift variant in exon 4 of SGIP1 through CRISPR/Cas9
由: Neelam Fatima, et al.
出版: (2024-10-01)

Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking
由: Ruthellen H. Anderson, et al.
出版: (2018-12-01)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
由: Vineet Anand, et al.
出版: (2022-09-01)

Enhanced production of IL-10 by dendritic cells deficient in CIITA.
由: Yee, C, et al.
出版: (2005)

CRISPR/Cas9 mediated Y-chromosome elimination affects human cells transcriptome
由: Ludovica Celli, et al.
出版: (2024-01-01)

Targeted elimination of Vancomycin resistance gene vanA by CRISPR-Cas9 system
由: Shuan Tao, et al.
出版: (2023-12-01)

CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
由: Rajeshwari Kundar, et al.
出版: (2022-11-01)